320 W Ohio St., Chicago, IL 60654 +1 (800) 397-3678

Interdependence Public Relations appoints health president

Michael Rinaldo has joined Interdependence Public Relations as president of its global health business. Rinaldo previously led Fleishman Hillard’s global healthcare practice for more than a decade and was general manager at dna Communications.

Fingerpaint promotes two

Nick Bartolomeo has been named head of media and performance marketing and Bryan O’Malley has been named head of technology and performance innovation at Fingerpaint. They will co-lead Fingerpaint’s newly formed SHIFT Performance Center of Excellence.

Syapse names commercial chief

David Pomerantz has been appointed chief commercial officer at Syapse, a real world evidence company. Pomerantz previously spent more than a decade at Kantar Health in various commercial operations positions.

City of Hope names marketing, communications head

Gulden Mesara has joined City of Hope as chief communications and marketing officer. Previously, she was group vice president of communications at Walgreens and has held comms roles with AbbVie and Pfizer.

National Pharmaceutical Council appoints interim CEO

Robert Dubois has been appointed National Pharmaceutical Council’s interim president and CEO. The board of directors will conduct a national search for a permanent replacement for Dan Leonard, who stepped down after more than 12 years as CEO.

Cerner appoints strategy chief

William Mintz has joined healthcare technology company Cerner as chief strategy officer. Previously, Mintz has held strategy roles with Leidos Holdings, Aetna, Care3 and Blue Cross Blue Shield of Massachusetts.

Blueprint Medicines names R&D president

Fouad Namouni has been named president, research and development at Blueprint Medicines. Previously, Namouni was global development lead for Bristol Myers Squibb’s cancer immunotherapy franchise.

Acadia Pharmaceuticals appoints head of R&D

Gudarz Davar has been named EVP and head of research and development at Acadia. Previously, Davar was VP and head of global neurology clinical development at Eli Lilly.

Galectin Therapeutics names CEO

Joel Lewis has been appointed chief executive officer of Galectin Therapeutics. He succeeds Harold Shlevin, who is retiring as CEO but will remain as a scientific and business consultant to Galectin.

The Escalator: Interdependence Public Relations appoints Michael Rinaldo health president

0

Interdependence Public Relations has brought on Michael Rinaldo as president, global health business. Rinaldo comes to Interdependence from dna Communications, part of the IPG and Weber Shandwick network, where he served as executive vice president & general manager. He was previously managing director, global healthcare at FleishmanHillard. At Interdependence, Rinaldo will be responsible for driving business strategy, delivering senior counsel, growing healthcare client relationships and strengthening the agency’s position and influence in the global healthcare business arena. “What excites me about Interdependence is its commitment to high-impact client relationships which start with a media engagement approach that leverages predictive analytics and AI to secure results,” he said.

Online gaming platform Roblox has named Barbara Messing chief marketing & employee experience officer. Messing was formerly senior vice president & chief marketing officer at Walmart. She has also served as CMO at TripAdvisor and vice president, customer experience at internet travel platform Hotwire. In her new post, Messing will oversee the development of the company’s brand strategy. She will report to Roblox co-founder and CEO Dave Baszucki. Directed at users under the age of 18, the platform says it has more than 150 million players worldwide.

Dermstore, an online beauty retailer, has hired Patrice Varni as chief marketing officer. Varni was previously chief customer officer at Correlle Brands, where she helped make the company’s legacy brands relevant to younger consumers. She has also served as chief customer officer at Arhaus Furniture, senior vice president of marketing for Tempur Sealy Brands and held marketing leadership roles at Levi Strauss. In her new role, Varni will be responsible for developing digital and brand transformations for Dermstore.

Anchorage-based Thompson & Co. Public Relations has promoted Ariel Walsh-Amand to chief operating officer, one of four women who have been appointed to the agency’s senior management team. Walsh-Amand has been with the agency for 11 years, and in her new position she will further contribute to its overall strategic direction and decision making. Ally Day, who has been with Thompson & Co for 10 years (most recently as senior account manager) will now serve as vice president, client services. The firm has also promoted Kailee Wallis, a founding member of its digital team, to digital director and has named Bri Kelly senior account manager. “Each of these women started at T&C as an intern or entry-level account coordinator, and I’m so proud and eager to see how their leadership will shape the future of the agency in their new positions,” said T&C president and CEO Jennifer Thompson.

https://www.odwyerpr.com/story/public/14835/2020-09-03/move-dnas-rinaldo-heads-interdependence.html

0

IRVINE, Calif., Sept. 3, 2020 /PRNewswire/ — Interdependence Public Relations announced today that Michael Rinaldo has joined the agency as President, Global Health Business. Rinaldo will be responsible for driving business strategy, delivering senior counsel, growing healthcare client relationships and strengthening Interdependence’s position and influence in the global healthcare business arena.

“What excites me about Interdependence is its commitment to high-impact client relationships which start with a media engagement approach that leverages predictive analytics and AI to secure results,” said Rinaldo. “We plan to combine in-market experience and a deep understanding of healthcare that clients demand, with an advanced technology-driven, results-focused approach that clients want.” Rinaldo joins a growing agency team that has collectively worked with some of the biggest healthcare brands and companies, including 15 of the Top 20 pharmaceutical companies. That experience is supercharged by Interviewed™, the most advanced predictive analytics and artificial intelligence (AI) technology in public relations, to maximize consistent media placements.

“Clients are looking for new options and innovative approaches that deliver predictable, targeted media coverage and full-scale communication solutions,” according to Rinaldo. “Interdependence has developed a technology platform called InterviewedTM which has helped increase pitch conversion for its clients by 300-400 percent, increasing traffic to websites, converting users, driving thought leadership and increasing client valuation. It’s an approach that’s ideally suited to the highly competitive healthcare space,” Rinaldo continued, “where breaking through is essential for meeting business goals and ultimately transforming patient lives.”

Over the course of a three-decade career in public relations, Rinaldo has built reputations, brands and businesses leveraging broad experience across a wide swath of healthcare communications, from public health and patient education to brand marketing and corporate reputation. Rinaldo’s ability to marry public health needs with business opportunity has helped influence opinion, shape policy and change diagnostic, treatment and care delivery. He led Fleishman Hillard’s global healthcare practice for more than a decade. Rinaldo followed that up by playing a lead role in building dna Communications – part of the IPG and Weber Shandwick network – into a global healthcare public relations agency.

“At Interdependence we’ll never lose sight of the importance of media and its ability to influence beliefs and behaviors,” said Rinaldo. “And we’ll never miss the chance to use media engagement as a springboard for deeper connections with important stakeholders like patients and healthcare providers.”

About INTERDEPENDENCE PUBLIC RELATIONS
Established in 2012, Interdependence is a full-service digital PR, investor relations and media communications firm supercharged by the most advanced technology ever in public relations to maximize consistent media placements in prestigious media and industry outlets. It is an experience that stands apart. We power constant media placements for some of the most notable companies in the world from leading Silicon Valley venture backed startups to firms with billions of dollars in annual revenues. Our team consists of former journalists and veteran public relations experts. Our strong relationships with journalist and editors across the board at national, global and industry trade publications give us an unrivaled presence and a competitive edge when it comes to strengthening our clients’ brands and reputations.

About INTERVIEWEDTM
Interdependence’s proprietary Interviewed™ technology works by breaking each of its client’s brands into roughly 50 key terms that best describe the product’s or company’s relevant attributes and positioning. Every minute, the technology uses AI and predictive analytics to search for breaking news, trending stories and emerging topics that relate to those key terms. Once it finds a match, it identifies journalists that cover that match term but have not yet written about the story. Agency professionals then craft a customized pitch and insert a client’s expert as a leading subject authority. In doing so, the writer or journalist becomes aware of the traffic-driven story, gains interest and doesn’t have to spend hours looking for resources for their feature or expert story.

But it’s not just about getting into a traffic-driven story. The technology’s analytics give Interdependence the insights and inspiration that help create and drive stories that are strategically and creatively aligned to a brand’s interests and business needs. Using the data and knowledge gained via Interviewed™ the agency is able to identify far more feature stories, expert stories, TV, radio, podcasts, Op-Ed and bylines, data-driven stories, campaign concepts and brand activations. It’s a full-scale strategy and communications solution.

https://www.prnewswire.com/news-releases/long-time-agency-healthcare-leader-michael-rinaldo-joins-interdependence-public-relations-301123988.html

0

IRVINE, CA — Former DNA Communications leader Michael Rinaldo has joined Interdependence Public Relations to head its global healthcare practice.

As president, global health business, Rinaldo will be responsible for driving business strategy, delivering senior counsel, growing healthcare client relationships and strengthening Interdependence’s position and influence in the global healthcare industry. The role is a new one for the firm.

“What excites me about Interdependence is its commitment to high-impact client relationships which start with a media engagement approach that leverages predictive analytics and AI to secure results,” said Rinaldo. “We plan to combine in-market experience and a deep understanding of healthcare that clients demand, with an advanced technology-driven, results-focused approach that clients want.”

Rinaldo left DNA earlier this summer after eight years running the IPG healthcare firm’s New York operation. He had a 23-year career as FleishmanHillard’s global healthcare managing director before that.

In August, Mike Rosich, who had been Marina Maher Communications’ creative strategy leader, was named Rinaldo’s successor, assuming oversight of DNA’s New York office as executive VP and general manager.

https://www.provokemedia.com/latest/article/michael-rinaldo-joins-interdependence-pr-as-global-healthcare-lead

0

Do NOT follow this link or you will be banned from the site!